239 related articles for article (PubMed ID: 34411566)
1. Vitamin D and the risk for cancer: A molecular analysis.
Carlberg C; Velleuer E
Biochem Pharmacol; 2022 Feb; 196():114735. PubMed ID: 34411566
[TBL] [Abstract][Full Text] [Related]
2. An update on vitamin D signaling and cancer.
Carlberg C; Muñoz A
Semin Cancer Biol; 2022 Feb; 79():217-230. PubMed ID: 32485310
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D and evolution: Pharmacologic implications.
Hanel A; Carlberg C
Biochem Pharmacol; 2020 Mar; 173():113595. PubMed ID: 31377232
[TBL] [Abstract][Full Text] [Related]
4. The concept of the personal vitamin D response index.
Carlberg C; Haq A
J Steroid Biochem Mol Biol; 2018 Jan; 175():12-17. PubMed ID: 28034764
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D Signaling in the Context of Innate Immunity: Focus on Human Monocytes.
Carlberg C
Front Immunol; 2019; 10():2211. PubMed ID: 31572402
[TBL] [Abstract][Full Text] [Related]
6. Molecular endocrinology of vitamin D on the epigenome level.
Carlberg C
Mol Cell Endocrinol; 2017 Sep; 453():14-21. PubMed ID: 28315703
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D: A Micronutrient Regulating Genes.
Carlberg C
Curr Pharm Des; 2019; 25(15):1740-1746. PubMed ID: 31298160
[TBL] [Abstract][Full Text] [Related]
8. Role of vitamin D and vitamin D receptor (VDR) in oral cancer.
Fathi N; Ahmadian E; Shahi S; Roshangar L; Khan H; Kouhsoltani M; Maleki Dizaj S; Sharifi S
Biomed Pharmacother; 2019 Jan; 109():391-401. PubMed ID: 30399574
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D and systemic cancer: is this relevant to malignant melanoma?
Osborne JE; Hutchinson PE
Br J Dermatol; 2002 Aug; 147(2):197-213. PubMed ID: 12174089
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D and Its Synthetic Analogs.
Maestro MA; Molnár F; Carlberg C
J Med Chem; 2019 Aug; 62(15):6854-6875. PubMed ID: 30916559
[TBL] [Abstract][Full Text] [Related]
11. Function of the vitamin D endocrine system in mammary gland and breast cancer.
Welsh J
Mol Cell Endocrinol; 2017 Sep; 453():88-95. PubMed ID: 28579119
[TBL] [Abstract][Full Text] [Related]
12. [Bone and calcium metabolism associated with malignancy. Vitamin D and cancer.].
Makishima M
Clin Calcium; 2018; 28(11):1465-1472. PubMed ID: 30374002
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide effects of chromatin on vitamin D signaling.
Hanel A; Malmberg HR; Carlberg C
J Mol Endocrinol; 2020 May; 64(4):R45-R56. PubMed ID: 32229699
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D and breast cancer risk.
Colston KW
Best Pract Res Clin Endocrinol Metab; 2008 Aug; 22(4):587-99. PubMed ID: 18971120
[TBL] [Abstract][Full Text] [Related]
15. [Molecular effects of vitamin D on cell cycle and oncogenesis].
Schmidt J; Wittenhagen P; Hørder M
Ugeskr Laeger; 1998 Jul; 160(30):4411-4. PubMed ID: 9691832
[TBL] [Abstract][Full Text] [Related]
16. [The impact of VDR gene polymorphisms on obesity, metabolic changes, bone mass disorders and neoplastic processes].
Wysoczańska-Klaczyńska A; Ślęzak A; Hetman M; Barg E
Pediatr Endocrinol Diabetes Metab; 2018; 24(2):96-105. PubMed ID: 30300431
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D Receptor Polymorphism and Cancer: An Update.
Rai V; Abdo J; Agrawal S; Agrawal DK
Anticancer Res; 2017 Aug; 37(8):3991-4003. PubMed ID: 28739681
[TBL] [Abstract][Full Text] [Related]
18. Impaired vitamin D sensitivity.
Máčová L; Bičíková M; Hampl R
Physiol Res; 2018 Nov; 67(Suppl 3):S391-S400. PubMed ID: 30484666
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D Receptor Polymorphisms and Cancer.
Gnagnarella P; Raimondi S; Aristarco V; Johansson HA; Bellerba F; Corso F; Gandini S
Adv Exp Med Biol; 2020; 1268():53-114. PubMed ID: 32918214
[TBL] [Abstract][Full Text] [Related]
20. The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature.
Köstner K; Denzer N; Müller CS; Klein R; Tilgen W; Reichrath J
Anticancer Res; 2009 Sep; 29(9):3511-36. PubMed ID: 19667145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
